Perospirone
Alternative Names: Lullan; SM 9018Latest Information Update: 05 Nov 2023
At a glance
- Originator Dainippon Sumitomo Pharma
- Developer Mitsubishi Tanabe Pharma Corporation; Sumitomo Pharma
- Class Antipsychotics; Isoindoles; Small molecules; Thiazoles
- Mechanism of Action Dopamine D2 receptor antagonists; Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Schizophrenia